Detalhe da pesquisa
1.
Hyperfractionation compared with standard fractionation in intensity-modulated radiotherapy for patients with locally advanced recurrent nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 trial.
Lancet
; 401(10380): 917-927, 2023 03 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-36842439
2.
Assessment of Prophylactic Internal Carotid Artery Management in Postradiation Nasopharyngeal Necrosis Patients.
Otolaryngol Head Neck Surg
; 170(2): 447-456, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38104320
3.
A novel endoscopic nasopharyngectomy by low-temperature plasma radiofrequency ablation in localized recurrent nasopharyngeal carcinoma.
Head Neck
; 46(2): 291-299, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37974339
4.
Fosaprepitant Weekly vs Every 3 Weeks for the Prevention of Concurrent Chemoradiotherapy-Induced Nausea and Vomiting: A Pilot Randomized Clinical Trial.
JAMA Netw Open
; 6(7): e2326127, 2023 07 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-37498596
5.
Camrelizumab Plus Apatinib in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma: An Open-Label, Single-Arm, Phase II Study.
J Clin Oncol
; 41(14): 2571-2582, 2023 05 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36735896
6.
Camrelizumab plus famitinib in patients with recurrent or metastatic nasopharyngeal carcinoma treated with PD-1 blockade: data from a multicohort phase 2 study.
EClinicalMedicine
; 61: 102043, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37415845
7.
Gemcitabine combined with apatinib and toripalimab in recurrent or metastatic nasopharyngeal carcinoma.
Med
; 3(10): 664-681.e6, 2022 10 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-36041429
8.
Efficacy of local therapy to metastatic foci in nasopharyngeal carcinoma: large-cohort strictly-matched retrospective study.
Ther Adv Med Oncol
; 14: 17588359221112486, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35860835